Wolfe Research initiated coverage of Clarivate (CLVT) with a Peer Perform rating and $4-$5 fair value range. The company has a strong market share with limited competition, but faces risks from tighter university and healthcare budgets, artificial intelligence disintermediation, and a relatively high net leverage ratio, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
- Clarivate to provide China Petrochemical with academic research, IP solutions
- Clarivate to provide library solutions, services to University of Melbourne
- Clarivate Increases Revolving Credit by $75 Million
- Milestone Scientific appoints Hines as CEO
- Clarivate’s Mixed Performance: Strong Financials Amid Strategic Uncertainty